BENZAMIDE, 5-((2,4-DIOXO-5-THIAZOLIDINYL)METHYL)-N-((2-HYDROXY-4-(TRIFLUOROMETHYL)PHENYL)METHYL)-2-METHOXY-
UNII M3O1BXL8Q5
Substance Identification & Data
This profile provides standardized clinical and technical data for Benzamide, 5-((2,4-dioxo-5-thiazolidinyl)methyl)-n-((2-hydroxy-4-(trifluoromethyl)phenyl)methyl)-2-methoxy-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M3O1BXL8Q5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 913646-26-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H17F3N2O5S CWURTXLVACVGKT-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Benzamide, 5-((2,4-dioxo-5-thiazolidinyl)methyl)-n-((2-hydroxy-4-(trifluoromethyl)phenyl)methyl)-2-methoxy-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.